Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Summary of Outstandng Stock Options) (Details)

v3.19.3
Stockholders' Equity (Summary of Outstandng Stock Options) (Details)
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Options Outstanding  
Balance | shares 3,163,354
Weighted Average Remaining Contractual Life (Years) 8 years 10 months 25 days
Weighted Average Exercise Price | $ / shares $ 2.54
Options Vested and Exercisable  
Balance | shares 1,346,174
Weighted Average Remaining Contractual Life (Years) 8 years 4 months 24 days
Weighted Average Exercise Price | $ / shares $ 4.18